.svg){kind=small}
Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chronic Health has shown a consistent performance in the Arizona market, particularly in the Tincture & Sublingual category, where it has maintained a steady second-place ranking from January through April 2025. This stability suggests a strong foothold in the market, with a notable increase in sales from $34,725 in January to $45,131 in April. The brand's performance in this category indicates a loyal customer base and effective product offerings that continue to resonate with consumers in Arizona.
In the Topical category, Chronic Health has demonstrated even greater dominance, holding the top position throughout the same period. This consistent first-place ranking highlights the brand's competitive edge and popularity among consumers seeking topical cannabis products. The sales figures reflect a slight fluctuation, peaking in March before a modest decline in April. Despite this, the brand's ability to maintain its leading position underscores its strength and appeal in the Arizona market. However, the absence of Chronic Health in the top 30 rankings in other states and categories could indicate areas for potential growth and expansion.
Competitive Landscape
In the competitive landscape of the Arizona topical cannabis market, Chronic Health has demonstrated a strong and consistent performance, maintaining its top rank from January through April 2025. This stability in rank is a testament to its robust market presence and consumer preference. In contrast, iLava has shown a notable upward trend, climbing from 5th place in January to 2nd place by April, which indicates a significant increase in consumer interest and sales momentum. Meanwhile, Drip Oils + Extracts, which started the year at the top, experienced a decline to 3rd place by February and remained there through April, suggesting a potential shift in consumer loyalty or market dynamics. These movements highlight the competitive pressure on Chronic Health to innovate and maintain its leading position amidst dynamic market changes.
Notable Products
In April 2025, the top-performing product for Chronic Health was Indica THC Glycerin Tincture (100mg THC, 1oz) in the Tincture & Sublingual category, maintaining its number one rank from March with sales of 1078 units. The CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz) rose to second place, showing significant improvement from its third-place position in March. The CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC, 2oz) consistently held the third spot, demonstrating steady demand in the Topical category. The CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz) slipped to fourth place, down from second in March. Meanwhile, the Pain Relief Ointment (90mg) entered the rankings in fifth place, having not been ranked in March.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
